Simplified Eradication of Helicobacter pylori for Patients With Penicillin-Allergy.
作者信息
Ryu Dae Gon
机构信息
Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Yangsan, Korea.
出版信息
Korean J Helicobacter Up Gastrointest Res. 2025 Mar;25(1):90-91. doi: 10.7704/kjhugr.2024.0069. Epub 2025 Mar 7.
Abstract
摘要
相似文献
1
Simplified Eradication of Helicobacter pylori for Patients With Penicillin-Allergy.青霉素过敏患者幽门螺杆菌的简化根除治疗
Korean J Helicobacter Up Gastrointest Res. 2025 Mar;25(1):90-91. doi: 10.7704/kjhugr.2024.0069. Epub 2025 Mar 7.
2
A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance.基于克拉霉素耐药性，对于青霉素过敏的患者，采用沃诺拉赞、克拉霉素和甲硝唑三联疗法进行幽门螺杆菌根除治疗。
Intern Med. 2023 Aug 15;62(16):2301-2306. doi: 10.2169/internalmedicine.0789-22. Epub 2023 Jan 12.
3
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.系统评价与荟萃分析：强效酸抑制剂——沃诺拉赞优于质子泵抑制剂，可根除克拉霉素耐药的幽门螺杆菌菌株。
Helicobacter. 2018 Aug;23(4):e12495. doi: 10.1111/hel.12495. Epub 2018 Jun 6.
4
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.幽门螺杆菌根除疗法与抗分泌非根除疗法（无论是否联合长期维持抗分泌疗法）用于预防消化性溃疡复发性出血的比较
Cochrane Database Syst Rev. 2004(2):CD004062. doi: 10.1002/14651858.CD004062.pub2.
5
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.幽门螺杆菌根除疗法与抗分泌非根除疗法（无论是否联合长期维持抗分泌疗法）用于预防消化性溃疡复发性出血的比较
Cochrane Database Syst Rev. 2003(4):CD004062. doi: 10.1002/14651858.CD004062.
6
Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin.头孢呋辛、左氧氟沙星、埃索美拉唑和枸橼酸铋钾四联疗法作为青霉素过敏患者根除幽门螺杆菌的一线治疗方案。
BMC Gastroenterol. 2019 Jul 25;19(1):132. doi: 10.1186/s12876-019-1056-3.
7
Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors for First-Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta-Analysis.比较钾竞争性酸阻滞剂和质子泵抑制剂作为一线幽门螺杆菌根除治疗的疗效和安全性：系统评价和网络荟萃分析。
Helicobacter. 2024 Nov-Dec;29(6):e13150. doi: 10.1111/hel.13150.
8
Efficacy of second-line regimens for eradication treatment: a systemic review and network meta-analysis.二线方案在根治性治疗中的疗效：系统评价和网络荟萃分析。
BMJ Open Gastroenterol. 2020 Sep;7(1). doi: 10.1136/bmjgast-2020-000472.
9
Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta-analysis.幽门螺杆菌感染患者强化教育的效果：系统评价和荟萃分析。
Helicobacter. 2022 Apr;27(2):e12880. doi: 10.1111/hel.12880. Epub 2022 Feb 12.
10
New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial.对青霉素过敏患者，新型方案作为幽门螺杆菌感染一线根除疗法的随机对照试验。
Helicobacter. 2023 Apr;28(2):e12956. doi: 10.1111/hel.12956. Epub 2023 Feb 8.
本文引用的文献
1
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南：幽门螺杆菌感染的治疗
Am J Gastroenterol. 2024 Sep 1;119(9):1730-1753. doi: 10.14309/ajg.0000000000002968. Epub 2024 Sep 4.
2
Simplified therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy.青霉素过敏患者的简化治疗：沃克帕唑-四环素联合疗法的随机对照试验
Gut. 2024 Aug 8;73(9):1414-1420. doi: 10.1136/gutjnl-2024-332640.
3
Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis.1990年至2022年亚太地区幽门螺杆菌的原发性抗生素耐药性：一项更新的系统评价和荟萃分析
Lancet Gastroenterol Hepatol. 2024 Jan;9(1):56-67. doi: 10.1016/S2468-1253(23)00281-9. Epub 2023 Nov 14.
4
Differences in beta-lactam and penicillin allergy: Beyond the West and focusing on Asia-Pacific.β-内酰胺类与青霉素过敏的差异：超越西方，聚焦亚太地区。
Front Allergy. 2022 Nov 22;3:1059321. doi: 10.3389/falgy.2022.1059321. eCollection 2022.
5
Evidence-Based Guidelines for the Treatment of Infection in Korea 2020.2020 年韩国感染治疗循证指南。
Gut Liver. 2021 Mar 15;15(2):168-195. doi: 10.5009/gnl20288.
6
First-line eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis.高和低克拉霉素耐药国家一线根除治疗：系统评价和网络荟萃分析。
Gut. 2018 Jan;67(1):20-27. doi: 10.1136/gutjnl-2016-311868. Epub 2016 Sep 26.
7
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.台湾幽门螺杆菌分离株的体外比较抗菌药敏试验和抗菌联合用药的协同活性。
J Microbiol Immunol Infect. 2015 Feb;48(1):72-9. doi: 10.1016/j.jmii.2012.08.021. Epub 2012 Oct 1.
8
The use and safety of doxycycline hyclate and other second-generation tetracyclines.盐酸多西环素及其他第二代四环素类药物的使用与安全性。
Expert Opin Drug Saf. 2008 Sep;7(5):571-7. doi: 10.1517/14740338.7.5.571.
Zotero 插件